InspireMD Inc. short interest in 2025
In 2025, InspireMD Inc.'s disclosed short interest ran from 0.66% of shares outstanding on 15 Jan 2025 to 0.08% on 31 Dec 2025, a change of -0.58 percentage points. The year's high was 1.23% on 15 Jul 2025 and its low 0.08% on 31 Dec 2025, averaging 0.57% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 6.66 days on 31 Jan 2025. Full history: InspireMD Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 0.66% (15 Jan 2025)
- End of year
- 0.08% (31 Dec 2025)
- Change
- -0.58 pp
- High
- 1.23% (15 Jul 2025)
- Low
- 0.08% (31 Dec 2025)
- Average
- 0.57%
- Highest days to cover
- 6.66 (31 Jan 2025)
- SEC filings marked
- 8
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 0.66% | 5.22 | |
| 31 Jan 2025 | 0.67% | 6.66 | |
| 14 Feb 2025 | 0.76% | 4.45 | |
| 28 Feb 2025 | 0.81% | 2.09 | |
| 14 Mar 2025 | 0.74% | 3.11 | 10-K filed, results (8-K) |
| 31 Mar 2025 | 0.81% | 4.12 | |
| 15 Apr 2025 | 0.65% | 4.37 | |
| 30 Apr 2025 | 0.61% | 5.17 | |
| 15 May 2025 | 0.63% | 3.09 | 10-Q filed, results (8-K) |
| 30 May 2025 | 0.67% | 5.02 | |
| 13 Jun 2025 | 0.64% | 3.81 | |
| 30 Jun 2025 | 1.05% | 1.00 | |
| 15 Jul 2025 | 1.23% | 3.69 | |
| 31 Jul 2025 | 1.03% | 2.85 | |
| 15 Aug 2025 | 0.73% | 3.41 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 0.31% | 1.12 | |
| 15 Sep 2025 | 0.30% | 3.13 | |
| 30 Sep 2025 | 0.27% | 1.00 | |
| 15 Oct 2025 | 0.28% | 1.64 | |
| 31 Oct 2025 | 0.28% | 1.68 | |
| 14 Nov 2025 | 0.10% | 1.00 | results (8-K), 10-Q filed |
| 28 Nov 2025 | 0.22% | 1.00 | |
| 15 Dec 2025 | 0.16% | 1.05 | |
| 31 Dec 2025 | 0.08% | 1.00 |
See also: InspireMD Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.